X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (222) 222
index medicus (207) 207
male (192) 192
female (139) 139
infectious diseases (117) 117
sepsis (112) 112
middle aged (110) 110
microbiology (108) 108
aged (91) 91
pharmacology & pharmacy (88) 88
animals (85) 85
adult (76) 76
immunology (61) 61
septic shock (60) 60
prospective studies (54) 54
rabbits (48) 48
cytokines (45) 45
health aspects (41) 41
mortality (41) 41
pneumonia (41) 41
diagnosis (37) 37
infections (36) 36
research (36) 36
aged, 80 and over (34) 34
analysis (34) 34
surgery (34) 34
care and treatment (33) 33
anti-bacterial agents - pharmacology (31) 31
anti-bacterial agents - therapeutic use (31) 31
infection (31) 31
inflammation (31) 31
infectious disease (30) 30
ventilator-associated pneumonia (30) 30
critical care medicine (29) 29
monocytes (29) 29
treatment outcome (29) 29
disease models, animal (28) 28
microbial sensitivity tests (28) 28
sepsis - immunology (27) 27
anti-bacterial agents - administration & dosage (26) 26
clarithromycin (26) 26
internal medicine (26) 26
medical colleges (26) 26
prognosis (26) 26
drug resistance, multiple, bacterial (25) 25
pharmacokinetics (25) 25
biochemistry & molecular biology (24) 24
cell biology (24) 24
pseudomonas aeruginosa - drug effects (24) 24
mice (23) 23
tumor necrosis factor-alpha - metabolism (23) 23
young adult (23) 23
apoptosis (22) 22
risk factors (22) 22
sepsis - drug therapy (22) 22
time factors (22) 22
malondialdehyde - blood (21) 21
pseudomonas aeruginosa (21) 21
dermatology (20) 20
expression (20) 20
patients (20) 20
sepsis - mortality (20) 20
therapy (20) 20
triggering receptor expressed on myeloid cells-1 (20) 20
bacterial pneumonia (19) 19
cells (19) 19
medicine & public health (19) 19
research article (19) 19
abridged index medicus (18) 18
antibiotics (18) 18
pathogenesis (18) 18
procalcitonin (18) 18
severity of illness index (18) 18
survival (18) 18
anti-bacterial agents - pharmacokinetics (17) 17
monocytes - immunology (17) 17
sepsis - microbiology (17) 17
severe sepsis (17) 17
survival analysis (17) 17
tumor necrosis factor-alpha - blood (17) 17
biomarkers (16) 16
interleukin-6 - blood (16) 16
rats (16) 16
critically-ill patients (15) 15
gastroenterology & hepatology (15) 15
immune response (15) 15
immunomodulation (15) 15
inflammatory response (15) 15
oncology (15) 15
pseudomonas-aeruginosa (15) 15
sepsis - blood (15) 15
sepsis - diagnosis (15) 15
tumor necrosis factor (15) 15
acute disease (14) 14
bacteremia (14) 14
ciprofloxacin (14) 14
clinical trials (14) 14
disease (14) 14
genetic aspects (14) 14
genetic predisposition to disease (14) 14
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, ISSN 0924-8579, 12/2015, Volume 46, pp. S1 - S1
Journal Article
British Journal of Dermatology, ISSN 0007-0963, 08/2018, Volume 179, Issue 2, pp. 413 - 419
Summary Background Despite the heavy purulence observed in hidradenitis suppurativa (HS), the kinetics of complement anaphylatoxins acting to prime chemotaxis... 
RECEPTOR | SKIN | DERMATOLOGY | Plasma | Complement component C5a | Therapeutic applications | Leukocytes (mononuclear) | Leukocytes (neutrophilic) | Patients | Chemotaxis | Complement activation | Cell activation | Tumor necrosis factor | Anaphylatoxins | Peripheral blood mononuclear cells | Membrane attack complex | Tumor necrosis factor-TNF | Tumors
Journal Article
JAMA Dermatology, ISSN 2168-6068, 09/2017, Volume 153, Issue 9, pp. 950 - 950
Journal Article
British Journal of Dermatology, ISSN 0007-0963, 11/2019, Volume 181, Issue 5, pp. 892 - 893
Linked Article: Scala et al. Br J Dermatol 2019; 181:1038–1045. 
Journal Article
British Journal of Dermatology, ISSN 0007-0963, 05/2019, Volume 180, Issue 5, pp. 1161 - 1168
Summary Background The introduction of adalimumab in the management of hidradenitis suppurativa (HS) raises questions regarding the cost‐efficacy of treatment.... 
RHEUMATOID-ARTHRITIS | BURDEN | CARE | DISEASE | DERMATOLOGY | National health insurance | Cost benefit analysis | Adalimumab | Analysis | Monoclonal antibodies | Tumor necrosis factor-TNF | Tumor necrosis factor | Patients | Cost control | Tumors
Journal Article
Pharmacology and Therapeutics, ISSN 0163-7258, 08/2014, Volume 143, Issue 2, pp. 225 - 245
Journal Article
British Journal of Dermatology, ISSN 0007-0963, 08/2018, Volume 179, Issue 2, pp. e123 - e123
... 
Journal Article
CRITICAL CARE, ISSN 1466-609X, 03/2018, Volume 22
Background: Evidence on the changes in the absolute counts of monocyte subpopulations in sepsis is missing. Methods: Firstly, absolute counts of circulating... 
CELLS | Gram-negative | Sepsis | Patrolling monocytes | Survival | Inflammatory monocytes | SUBSET | BLOOD | CRITICAL CARE MEDICINE
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 2017, Volume 64, Issue 5, pp. 565 - 571
Journal Article
SHOCK, ISSN 1073-2322, 09/2019, Volume 52, Issue 3, pp. 307 - 317
Journal Article
British Journal of Dermatology, ISSN 0007-0963, 11/2017, Volume 177, Issue 5, pp. 1401 - 1409
Journal Article